Puneet Souda
Stock Analyst at Leerink Partners
(1.58)
# 3,311
Out of 4,905 analysts
213
Total ratings
47.4%
Success rate
-1.58%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QTRX Quanterix | Downgrades: Market Perform | $12 → $8 | $5.37 | +48.98% | 12 | Apr 30, 2025 | |
| NEO NeoGenomics | Downgrades: Market Perform | $25 → $9 | $6.24 | +44.23% | 10 | Apr 30, 2025 | |
| HOLX Hologic | Downgrades: Market Perform | $80 → $75 | $63.99 | +17.21% | 7 | Feb 6, 2025 | |
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $4.47 | +369.80% | 7 | Dec 9, 2024 | |
| MASS 908 Devices | Downgrades: Market Perform | $12 → $4 | $6.71 | -40.34% | 6 | Nov 13, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $23.51 | +70.14% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $138.90 | +7.99% | 7 | Oct 17, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $287.53 | +30.42% | 15 | Aug 1, 2024 | |
| CYRX Cryoport | Downgrades: Market Perform | $30 → $10 | $7.19 | +39.08% | 6 | Jul 13, 2023 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $630 | $414.75 | +51.90% | 19 | Jul 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $35 | $16.54 | +111.61% | 11 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $145 | $113.99 | +27.20% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $190.05 | +57.85% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $96.14 | +160.04% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $52.02 | +111.46% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $50.46 | +48.63% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $116.25 | +72.04% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $4.48 | +301.79% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $1.96 | +206.91% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $35.17 | -14.70% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $40.55 | +114.55% | 13 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $140 | $46.46 | +201.33% | 5 | Feb 24, 2022 |
Quanterix
Apr 30, 2025
Downgrades: Market Perform
Price Target: $12 → $8
Current: $5.37
Upside: +48.98%
NeoGenomics
Apr 30, 2025
Downgrades: Market Perform
Price Target: $25 → $9
Current: $6.24
Upside: +44.23%
Hologic
Feb 6, 2025
Downgrades: Market Perform
Price Target: $80 → $75
Current: $63.99
Upside: +17.21%
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $4.47
Upside: +369.80%
908 Devices
Nov 13, 2024
Downgrades: Market Perform
Price Target: $12 → $4
Current: $6.71
Upside: -40.34%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $23.51
Upside: +70.14%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $138.90
Upside: +7.99%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $287.53
Upside: +30.42%
Cryoport
Jul 13, 2023
Downgrades: Market Perform
Price Target: $30 → $10
Current: $7.19
Upside: +39.08%
Thermo Fisher Scientific
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $414.75
Upside: +51.90%
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $16.54
Upside: +111.61%
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $113.99
Upside: +27.20%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $190.05
Upside: +57.85%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $96.14
Upside: +160.04%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $52.02
Upside: +111.46%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $50.46
Upside: +48.63%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $116.25
Upside: +72.04%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $4.48
Upside: +301.79%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $1.96
Upside: +206.91%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $35.17
Upside: -14.70%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $40.55
Upside: +114.55%
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $46.46
Upside: +201.33%